U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876713) titled 'Acetazolamide to Reduce Spinal Fluid Leaks After Spine Surgery.' on Oct. 09.
Brief Summary: This study aims to evaluate the effectiveness and safety of acetazolamide in helping patients recover from accidental dural tears during spine surgery. Adding acetazolamide to standard post-surgery care is hypothesized to be a safe and effective way to reduce spinal fluid leakage, ease headaches, and speed up recovery.
Study Start Date: April 06, 2025
Study Type: INTERVENTIONAL
Condition:
Cerebrospinal Fluid Leak
Dural Tear
Incidental Durotomy
Intervention:
DRUG: Acetazolamide
250 mg three times daily for 2 weeks
OTHER: Standard Care ...